Zobrazeno 1 - 9
of 9
pro vyhledávání: '"L S Lang"'
Autor:
GJ German, Richard Garceau, Ramzi Fattouh, Theodore I. Kuschak, Guillaume Desnoyers, Nathan Zelyas, Jonathan B. Gubbay, Yang Yu, Amanda L S Lang, Kerry Dust, Ryan R. McDonald, Marek Smieja, Robert Needle, Candy Rutherford, Tony Mazzulli, Jason J. LeBlanc, Hugues Charest, George Zahariadis, Todd F. Hatchette, Robert A. Kozak, Paul N Levett, Samira Mubareka, Natalie Prystajecky, Nathalie Bastien, Mel Krajden, Yan Li, Dionne Marcino, Sandra Radons Arneson
Publikováno v:
Journal of Clinical Virology
Journal of clinical virology, 128:104433
Journal of clinical virology, 128:104433
With emergence of pandemic COVID-19, rapid and accurate diagnostic testing is essential. This study compared laboratory-developed tests (LDTs) used for the detection of SARS-CoV-2 in Canadian hospital and public health laboratories, and some commerci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37d83c77e725a8edcd1d6e2a2058af08
Autor:
Todd F. Hatchette, Irene Martin, May Elsherif, Louis Valiquette, Karen Green, Walter Demczuk, Amanda L S Lang, Makeda Semret, Guy Boivin, Jason J. LeBlanc, William R. Bowie, Lingyun Ye, Allison McGeer, Jennie Johnstone, Anne E. McCarthy, Ardith Ambrose, Shelly A. McNeil, Sylvie Trottier, Hayley D. Gillis, Donna MacKinnon-Cameron, Melissa K. Andrew, Duncan Webster, Mark Loeb
Publikováno v:
Open Forum Infectious Diseases
Background Streptococcus pneumoniae can colonizes the human nasopharynx, and can cause life-threatening infections like community-acquired pneumonia (CAP) and invasive pneumococcal diseases (IPD). In Canada, the 13-valent conjugate vaccine (PCV13) wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bd2bb33759c2ad6fb8280212b9657ff
https://doi.org/10.1093/ofid/ofz360.2391
https://doi.org/10.1093/ofid/ofz360.2391
Autor:
Todd F. Hatchette, Duncan Webster, Guy Boivin, Louis Valiquette, Jason J. LeBlanc, William R. Bowie, Makeda Semret, Jennie Johnstone, Amanda L S Lang, Sylvie Trottier, Anne E. McCarthy, Lingyun Ye, Ardith Ambrose, Mark Loeb, Donna MacKinnon-Cameron, Walter Demczuk, Karen Green, Hayley D. Gillis, Shelly A. McNeil, Melissa K. Andrew, May Elsherif, Allison McGeer, Irene Martin
Publikováno v:
Open Forum Infectious Diseases
Background In healthy adults aged ≥65 years, direct immunization with the 13-valent pneumococcal conjugate vaccine (PCV13) was shown effective at preventing vaccine-type pneumococcal community-acquired pneumonia (pCAP) and invasive pneumococcal dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46f89751003b0c9e81d731f47fd3cb60
http://europepmc.org/articles/PMC6810608
http://europepmc.org/articles/PMC6810608
Autor:
Gustav Graff, Joan M. Spellman, L S Lang, D.W. Parnell, Lori K. Weimer, Steven T. Miller, Milton T. Brady, D.J. Stephens, John M. Yanni, Daniel A. Gamache
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics. 12:389-400
Olopatadine (AL-4943A; KW-4679) [(z)-11-[3-(dimethylamino)propylidene]-6, 11-dihydrodibenz[b,e]oxepine-2 acetic acid hydrochloride] is an anti-allergic agent which inhibits mast cell mediator release and possesses histamine H1 receptor antagonist act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c11e46a79b5d5a81002e5be8bf4779b
https://doi.org/10.1089/jop.1996.12.389
https://doi.org/10.1089/jop.1996.12.389
Autor:
S. M. Robertson, L. S. Lang
Publikováno v:
Agents and Actions. 42:167-172
Leflunomide (LEF) is a novel immunomodulator which has been reported to be efficacious in experimental models of systemic autoimmune diseases and in treating rheumatoid arthritis in man. Leflunomide's ability to ameliorate ocular disease processes wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::888607525c40b4bf570713e897eb60f7
https://doi.org/10.1007/bf01983486
https://doi.org/10.1007/bf01983486
Publikováno v:
International Archives of Allergy and Immunology. 101:102-106
The antiallergic compound, lodoxamide, was evaluated for its abilities to attenuate a local allergic reaction in rat conjunctiva in vivo and to inhibit rat conjunctival mast cell mediator release in vitro. Topically applied lodoxamide (0.01, 0.10 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bfc9972d124a24ffef6ee6f8cf55035
https://doi.org/10.1159/000236505
https://doi.org/10.1159/000236505
Publikováno v:
Investigative ophthalmologyvisual science. 35(10)
The efficacy of the antirejection drug leflunomide was evaluated in a rat model of penetrating keratoplasty.Corneal grafts from inbred Lewis rats were transplanted orthotopically to inbred Wistar-Furth (WF) recipients. WF rats received either Lefluno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa1b7562fc3b3f7257da69696e3177e1
https://pubmed.ncbi.nlm.nih.gov/8088966
https://pubmed.ncbi.nlm.nih.gov/8088966
Publikováno v:
Regional immunology. 5(2)
Choroidal mast cells have been implicated in experimental autoimmune uveitis (EAU), an ocular inflammatory disease induced by S-antigen. Our data confirm that choroidal mast cell numbers decrease with clinical onset of S-antigen-induced EAU in Lewis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::78922a091de39cdfd34f2cd5d5d38b50
https://pubmed.ncbi.nlm.nih.gov/8217552
https://pubmed.ncbi.nlm.nih.gov/8217552
Autor:
S. M. Robertson, L. S. Lang
Publikováno v:
Agents and Actions. 41:C274-C275
Leflunomide (LEF), an isoxazole derivative under development for the treatment of rheumatoid arthritis, is a novel immunomodulator which has been reported to be efficacious in experimental models of transplantation and systemic autoimmune diseases. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b407a2a1e91a69490c559528968b872a
https://doi.org/10.1007/bf01987667
https://doi.org/10.1007/bf01987667